ECSP077996A - Derivados de piridona para modular el sistema de proteína cinasa activada por estrés - Google Patents
Derivados de piridona para modular el sistema de proteína cinasa activada por estrésInfo
- Publication number
- ECSP077996A ECSP077996A EC2007007996A ECSP077996A ECSP077996A EC SP077996 A ECSP077996 A EC SP077996A EC 2007007996 A EC2007007996 A EC 2007007996A EC SP077996 A ECSP077996 A EC SP077996A EC SP077996 A ECSP077996 A EC SP077996A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- modulate
- piridona
- sapk
- kinase protein
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000001253 Protein Kinase Human genes 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 2
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 abstract 2
- 108060006633 protein kinase Proteins 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- ISWRGOKTTBVCFA-UHFFFAOYSA-N pirfenidone Chemical class C1=C(C)C=CC(=O)N1C1=CC=CC=C1 ISWRGOKTTBVCFA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a métodos para modular un sistema de proteína cinasa activada por estrés (SAPK) con un compuesto activo, en donde el compuesto activo exhibe baja potencia para inhibición de al menos, una p38 MAPK; y en donde el contacto se conduce a una concentración que modula el SAPK que está a una concentración inhibitoria de bajo porcentaje, para inhibición de al menos, una p38 MAPK por el compuesto. También se describen derivados de pirfenidona. Estos derivados pueden modular un sistema de proteína cinasa activada por estrés (SAPK).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67947105P | 2005-05-10 | 2005-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP077996A true ECSP077996A (es) | 2008-02-20 |
Family
ID=39921062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2007007996A ECSP077996A (es) | 2005-05-10 | 2007-12-10 | Derivados de piridona para modular el sistema de proteína cinasa activada por estrés |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101237869A (es) |
| EC (1) | ECSP077996A (es) |
| ZA (1) | ZA200709593B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101874801A (zh) * | 2009-04-29 | 2010-11-03 | 中南大学 | 吡啶酮类化合物在制备治疗糖尿病肾病药物中的用途 |
| CN102149682B (zh) * | 2009-05-25 | 2012-12-05 | 中南大学 | 1-(取代芳基)-5-三氟甲基-2-(1h)吡啶酮化合物及其盐的制备方法及其用途 |
| EP2474533B1 (en) | 2009-05-25 | 2015-02-25 | Central South University | Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications |
| RU2692485C2 (ru) * | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
| CN105884680B (zh) * | 2016-06-16 | 2019-06-25 | 杨若一 | 吡非尼酮衍生物及其制备方法与用途 |
| CN106045971B (zh) * | 2016-06-16 | 2018-12-21 | 杨若一 | 吡非尼酮衍生物及其制备方法 |
| WO2021057599A1 (zh) * | 2019-09-26 | 2021-04-01 | 深圳先进技术研究院 | 吡非尼酮在制备防治类风湿性关节炎的药物中的应用 |
| CN112986065B (zh) * | 2021-02-08 | 2021-08-31 | 杭州同创医学检验实验室有限公司 | 一种用于血细胞分析仪的全血质控品及其制备方法 |
| CN114716365B (zh) * | 2022-01-04 | 2024-03-01 | 大连理工大学 | 一类n-取代苯基-2-吡啶酮化合物或其可药用盐在治疗肺纤维化中的应用 |
| WO2024235145A1 (zh) * | 2023-05-12 | 2024-11-21 | 大连理工大学 | 一类n-取代苯基-2-吡啶酮及内过氧化物的制备和应用 |
| WO2026077440A1 (en) * | 2024-10-12 | 2026-04-16 | Beijing Continent Pharmaceuticals Co., Ltd. | Compositions and methods for preventing and treating chronic renal failure |
-
2006
- 2006-05-09 ZA ZA200709593A patent/ZA200709593B/xx unknown
- 2006-05-09 CN CNA2006800251605A patent/CN101237869A/zh active Pending
-
2007
- 2007-12-10 EC EC2007007996A patent/ECSP077996A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200709593B (en) | 2009-06-24 |
| CN101237869A (zh) | 2008-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI200700289A (es) | Derivados de piridona para modular el sistema de proteína cinasa activada por estrés | |
| MX2010012848A (es) | Compuestos y metodos para tratar trastornos inflamatorios y fibroticos. | |
| WO2006026473A3 (en) | METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS | |
| BR112012000968B8 (pt) | composto, composição e método para inibir uma fosfatidil inositol-3 cinase. | |
| EA200900749A1 (ru) | 1,4-диаминобициклические аналоги ретигабина как модуляторы калиевых каналов | |
| CR10860A (es) | Compuestos y metodos para modulacion de cinasas, e indicaciones para ello | |
| MX2007001127A (es) | Moduladores de pirrolo-piridina cinasa. | |
| MX2009011210A (es) | Inhibidores de mcl1 de indol 7-no sustituido. | |
| SV2009003235A (es) | Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476m | |
| SV2009003290A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina | |
| NO20091083L (no) | Organiske forbindelser | |
| EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
| NO20081454L (no) | Met-kinaseinhibitorer | |
| EA200701257A1 (ru) | Пирролопиразолы в качестве сильнодействующих ингибиторов киназы | |
| BRPI0510663A (pt) | pelo menos uma entidade quìmica, composição, métodos para modular atividade da cinesina cenp-e, para inibir cenp-e, e para tratar uma doença proliferativa celular, e, uso de pelo menos uma entidade quìmica | |
| NO20081042L (no) | PPAR aktive forbindelser | |
| CR9677A (es) | Derivados de pirrolo(2,3-b) piridina como inhibidores de proteina cinasa | |
| CU23829B1 (es) | Compuestos y composiciones como inhibidores de las proteínas cinasas | |
| ECSP088860A (es) | Compuestos y composiciones como moduladores de la senda de hedgehog | |
| BRPI0517253A (pt) | compostos e composições como moduladores de trajetória de ouriço | |
| CR11264A (es) | Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa | |
| MY144672A (en) | Inhibitors of cytosolic phospholipase a2 | |
| ATE502940T1 (de) | Ä2,6-ünaphthyridine als proteinkinasehemmer | |
| NO20090764L (no) | 4-hydroksytiobenzamidderivater og legemidler | |
| DE602005022826D1 (de) | Kontrolle der Androgen Rezeptor-abhängigen Gen Expression durch Hemmung der Aminoxidase Aktivität der Lysin spezifischen Demethylase (LSD1) |